Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Other Non-Current Liabilities (2017 - 2021)

Equillium (EQ) posted quarterly Other Non-Current Liabilities of $17000.0 for Q3 2021, down 76.06% year-over-year from $71000.0 in Q3 2020, and little changed quarter-over-quarter from $17000.0 in Q2 2021.

Analysis

Equillium (EQ) Other Non-Current Liabilities (2017 - 2021) Analysis & Trends

Equillium (EQ) has reported Other Non-Current Liabilities for 5 consecutive years, with $17000.0 the latest figure, recorded in Q3 2021.

  • In Q3 2021, Other Non-Current Liabilities fell 76.06% year-over-year to $17000.0; the TTM figure through Sep 2021 stood at $17000.0 (down 76.06% YoY), while the FY2020 annual figure was $54000.0, down 57.48% from the prior year.
  • Other Non-Current Liabilities steadied at $17000.0 in Q3 2021 per EQ's latest filing, from $17000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $775842.0 in Q4 2017 and bottomed at $17000.0 in Q2 2021.
  • Historically, Other Non-Current Liabilities has averaged $149130.5 across 5 years, with a median of $99000.0 in 2020.
  • Annual changes were most pronounced in 2019 — Other Non-Current Liabilities fell 1.83% — and 2021, when it tumbled 81.11%.
  • Equillium's Other Non-Current Liabilities stood at $775842.0 in 2017, then slumped by 74.22% to $200000.0 in 2018, then plunged by 36.5% to $127000.0 in 2019, then slumped by 57.48% to $54000.0 in 2020, then tumbled by 68.52% to $17000.0 in 2021.
  • Business Quant data shows EQ's Other Non-Current Liabilities at $17000.0 in Q3 2021, $17000.0 in Q2 2021, and $35000.0 in Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Equillium 249.33 Mn 249.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 17,000.00
Jun 30, 2021 17,000.00
Mar 31, 2021 35,000.00
Dec 31, 2020 54,000.00
Sep 30, 2020 71,000.00
Jun 30, 2020 90,000.00
Mar 31, 2020 108,000.00
Dec 31, 2019 127,000.00
Sep 30, 2019 146,000.00
Dec 31, 2018 200,000.00
Sep 30, 2018 2.38 Mn
Dec 31, 2017 775,842.00